Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on May 29, 2025
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
GlobeNewswire
·
May 29, 2025
LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study is currently enrolling in dose escalation Poster to be presented June 2, 2025, …
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that members …
AGM Group Holdings Inc. Announces Effective Date of 50 for 1 Share Consolidation
GlobeNewswire
·
May 29, 2025
Beijing, May 29, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today …
Amneal to Participate at Upcoming Investor Conferences in June
GlobeNewswire
·
May 29, 2025
BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on June 5, 2025, with company presentation at 9:20 AM ET, and …
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
BRISBANE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Zscaler Reports Third Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
May 29, 2025
Third Quarter Highlights Revenue grows 23% year-over-year to $678.0 million Calculated billings grows 25% year-over-year to $784.5 million Deferred revenue grows 26% year-over-year to $1,985.0 million GAAP net loss of $4.1 million compared to GAAP net …
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
GlobeNewswire
·
May 29, 2025
FOSTER CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
GlobeNewswire
·
May 29, 2025
SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will …
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025
GlobeNewswire
·
May 29, 2025
– 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – …
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June: Jefferies 2025 Global Healthcare Conference on Thursday, June 5 …
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
May 29, 2025
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis …
Mavenir kooperiert mit Three UK und Red Hat: 5G-Geschwindigkeit in Glasgow durch ersten Open-RAN-Kleinzellen-Rollout in Großbritannien verdoppelt
GlobeNewswire
·
May 29, 2025
Mavenir Open vRAN und O-RAN-konforme Small Cells sind entscheidend für den Erfolg der Einführung von Three UK im Stadtzentrum von Glasgow – sie verbessern die Netzabdeckung und Kapazität in einem stark frequentierten, dicht bebauten Stadtgebiet …
Colaboración de Mavenir con Three UK y Red Hat duplica las velocidades 5G en Glasgow en el primer lanzamiento de celdas pequeñas Open RAN en el Reino Unido
GlobeNewswire
·
May 29, 2025
Las celdas pequeñas Open vRAN y compatibles con O-RAN de Mavenir son fundamentales para el éxito del lanzamiento de Three UK en el centro de la ciudad de Glasgow, aumentando la cobertura y la capacidad en un entorno urbano denso y de alta demanda La prueba …
שיתוף פעולה של Mavenir עם Three UK ו-Red Hat מכפיל את מהירויות ה-5G בגלזגו בפריסת תאי Open RAN קטנים ראשונה בבריטניה
GlobeNewswire
·
May 29, 2025
לתאים הקטנים תואמי Open vRAN ו-O-RAN של Mavenir יש חלק מרכזי בהצלחת הפריסה של Three UK במרכז גלזגו - שמחזקת את הכיסוי והקיבולת בסביבה עירונית צפופה בה הביקוש גבוה ניסוי פורץ דרך מדגים את היתרון של פריסת תאי Open RAN קטנים לצד רשתות מאקרו קיימות כדי לפתור …
Mavenir, Three UK et Red Hat, une collaboration qui marque le premier déploiement de petites cellules Open RAN au Royaume-Uni et permet de doubler la vitesse de la 5G à Glasgow
GlobeNewswire
·
May 29, 2025
Les petites cellules Open vRAN (ou Réseau d’Accès Radio Ouvert virtualisé) de Mavenir sont conformes à la norme O-RAN. Elles sont au cœur du succès du déploiement de Three UK dans le centre-ville de Glasgow et améliorent la couverture et la capacité dans …
マベニア (Mavenir)、スリーUK (Three UK) およびレッドハット (Red Hat) と提携し、英国初のオープンRAN (Open RAN) スモールセル展開によりグラスゴーの5G通信速度を2倍に向上
GlobeNewswire
·
May 29, 2025
マベニアのオープンvRAN (Open vRAN) およびO-RAN準拠のスモールセルは、スリーUKによるグラスゴー市中心部における展開の成功で中心的役割を果たし、高需要・高密度の都市環境全体のカバレッジと容量を拡大 この画期的なトライアルは、ブラックスポットの問題を解決するために、既存のマクロネットワークと共にオープンRANスモールセルを展開することの利点を実証する スコットランド・グラスゴー発 , May 30, 2025 (GLOBE NEWSWIRE) -- …
Kolaborasi Mavenir dengan Three UK dan Red Hat Gandakan Kecepatan 5G Glasgow dalam Peluncuran Small Cells Open RAN Pertama di Inggris
GlobeNewswire
·
May 29, 2025
Small cells Mavenir Open vRAN dan berstandar O-RAN menjadi kunci keberhasilan peluncuran Three UK di Pusat Kota Glasgow, karena mampu meningkatkan cakupan dan kapasitas di lingkungan perkotaan padat dengan permintaan tinggi Uji coba penting ini menunjukkan …
Colaboração da Mavenir com Three UK e Red Hat Dobra a Velocidade 5G em Glasgow no Lançamento do UK-First Open RAN Small Cells Roll-Out
GlobeNewswire
·
May 29, 2025
Small cells compatíveis com Mavenir Open vRAN e O-RAN centrais para o sucesso da implantação no Glasgow City Centre do Three UK – aumentando a cobertura e a capacidade em um ambiente urbano denso e de alta demanda O teste decisivo demonstra o benefício da …
Mavenir จับมือกับ Three UK และ Red Hat เพื่อทวีความเร็ว 5G ในเมืองกลาสโกว์เป็นสองเท่าในการเปิดตัว Open RAN Small Cells…
GlobeNewswire
·
May 29, 2025
เซลล์ขนาดเล็กที่ทำงานร่วมกันได้กับ Open vRAN และ O-RAN ของ Mavenir ซึ่งถือเป็นศูนย์กลางแห่งความสำเร็จของการเปิดตัวศูนย์กลางเมืองกลาสโกว์ของ Three UK ช่วยเพิ่มความครอบคลุมและความจุในสภาพแวดล้อมเมืองที่มีความต้องการสูงและหนาแน่น …